Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
An infusion of umbilical cord blood does not improve social skills in autistic children, according to results from the largest, most rigorous test of the therapy for autism to date.
A new method for electroencephalography source localization can noninvasively identify brain networks involved in generating seizures in people with epilepsy.
Autistic preschoolers may get too little therapy and too much medication, according to a new study.
Some families do not have the financial ability or time to participate in clinical trials for autism. New technologies may enable them to participate from their homes.
Lowering the levels of a protein called tau, best known for its involvement in Alzheimer’s disease, improves behavior in two mouse models of autism.
Melatonin appears to be safe for long-term use in autistic children who have difficulty sleeping.
Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade’s worth of data suggests that is not true.
Many clinical trials, including those related to autism, do not report their results within a year of their completion.
Many people with autism have difficulty falling and staying asleep, but there may be ways to help them.
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can’t we tell if these medications work similarly in children with the condition?
